ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

‘Approval to Apply’ For Proton Facility Upgrade Denied

February 24, 1989

In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License

November 10, 1995